IL6 and neoplasm: TAM-derived IL-10 and interactions with MDSCs result in decreased IL-6, IL-12, and MHCII, and increased anti-inflammatory IL-10, TGF-β1, and Foxp3+ Treg frequencies to facilitate tumor growth and immune tolerance (41, 42).